Name: UMIN ID:
Unique ID issued by UMIN | UMIN000034477 |
---|---|
Receipt number | R000037970 |
Scientific Title | Efficacy and safety of eribulin in combination with trastuzumab and pertuzumab for HER2-positive advanced breast cancer |
Date of disclosure of the study information | 2018/11/01 |
Last modified on | 2020/10/27 20:33:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/10/13 15:36:42 | ||
2 | Update | 2020/10/27 20:32:48 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
3 | Update | 2020/10/27 20:33:31 | Last follow-up date |